CPT 64450 is a high-risk “catch-all” nerve block code: it is clinically common, but it is also commonly denied or recouped when documentation does not clearly establish:
Medicare policy materials reinforce that peripheral nerve blocks are intended for focused, anatomically coherent services—not generalized neuropathy treatment or subcutaneous “tissue injections” billed as nerve blocks.
CPT 64450 describes an injection of anesthetic agent (and/or steroid) for an other peripheral nerve or branch. In coding terms, it functions as a nondestructive peripheral nerve block used for diagnostic or therapeutic purposes when the targeted nerve/branch is not described by a more specific CPT nerve-block code. The defining compliance principle is that 64450 is not a general “pain injection” code; it is a nerve block code and must be supported as such by the record.
Practical boundary: If the record cannot clearly answer “Which nerve was blocked?” the claim is structurally vulnerable. Medicare policy materials emphasize that injections not involving the structures described by 64450 (i.e., not a true nerve block) should not be coded as 64450.
CPT uses a family of nerve-block codes for specific anatomic nerves/regions. 64450 is the residual category—appropriate only when a more specific nerve-block code does not describe the service. The defensible approach is to confirm that the targeted nerve is not already represented by a dedicated code and that the service is truly a peripheral nerve/branch block as documented.
flowchart TD
A["Peripheral nerve injection performed"] --> B{"Is there a more specific\nCPT nerve block code\nfor this nerve?"}
B -->|"Yes"| C["Use the specific code\ne.g. 64455 for Morton's neuroma"]
B -->|"No"| D{"Is the injection targeting\na named peripheral nerve\nor branch?"}
D -->|"No"| E["Do NOT use 64450\nConsider soft-tissue\ninjection codes"]
D -->|"Yes"| F{"Was the block performed\nas anesthesia integral\nto another procedure?"}
F -->|"Yes"| G["Do NOT report 64450\nseparately - bundled\ninto surgical package"]
F -->|"No"| H{"Is the indication a\nfocal mononeuropathy\nor nerve-specific condition?"}
H -->|"No - systemic neuropathy"| I["64450 likely non-covered\nby Medicare LCD"]
H -->|"Yes"| J["Report 64450 with\ncomplete documentation"]
J --> K{"Ultrasound guidance\nused and documented?"}
K -->|"Yes"| L["Consider reporting\n76942 per payer rules"]
K -->|"No"| M["64450 only"]
In real-world practice, 64450 is often used for focused, peripheral mononeuropathic pain or focal neuralgia where an anatomically named peripheral nerve/branch is targeted and no more specific CPT code applies. Emergency medicine coding guidance commonly discusses peripheral nerve blocks (including upper-extremity nerve blocks) under 64450 when the nerve does not map to a more specific code, and it emphasizes correct bundling logic when performed as part of another service.
Medicare coverage policy for peripheral nerve blocks stresses that the service should be clinically reasonable and expected to resolve or substantially improve symptoms within a limited number of injections at the same site; repeated procedures without durable benefit raise coverage concerns.
For Medicare, peripheral nerve block coverage is implemented through local coverage determinations (LCDs) and related billing/coding articles. These documents operationalize “reasonable and necessary” using (1) indications/limitations, (2) diagnosis code support logic, and (3) utilization controls. The core Medicare compliance concept is that 64450 must be justified as a targeted nerve block for a supported condition—not a generalized pain intervention.
Medicare LCD guidance for peripheral nerve blocks emphasizes that the signs and symptoms supporting a block should resolve after one to three injections at a specific site, and it expresses skepticism (insufficient evidence) regarding use for neuropathies caused by underlying systemic diseases. This policy framing is important because it directly affects both initial claim payment and post-payment review.
Medicare’s billing/coding article for peripheral neuropathy nerve blocks includes explicit direction that certain therapies and injections are not to be coded with 64450, and it is commonly used by contractors to justify denials when claims appear to represent non-nerve injections or non-covered neuropathy treatment. In practical audits, the diagnosis on the claim must match the story in the note: a focal nerve problem with a plausible target and a reasonable therapeutic/diagnostic goal.
High-yield Medicare risk point: When the clinical note uses vague language (e.g., “neuropathy,” “pain,” “neuritis” without a specific nerve distribution and target), contractors may treat the service as non-covered or not meeting the structure of 64450. Medicare policy materials explicitly discuss inappropriate use when the injection does not involve the nerve structures described by the code.
Documentation must make the service independently auditable: a reviewer should be able to reconstruct what was done, why it was needed, and why 64450 (rather than another code) is correct. Medicare policy materials stress that documentation must support the billed service and that injections not matching the nerve-block structure should not be billed as 64450.
For services that resemble other injection categories (tendon sheath, ligament, Morton’s neuroma-related injections), Medicare coding guidance is commonly used to enforce code selection. The record should make it clear that this was a nerve block—not a tendon/ligament injection and not an injection scenario where a more specific nerve-related CPT code applies.
For unilateral services, payers commonly expect laterality (RT/LT) when relevant. For bilateral performance, coding often requires appropriate bilateral reporting conventions per payer rules. Because bilateral rules can vary by payer, the best defensibility strategy is to ensure the operative/procedure note clearly documents laterality and whether the blocks were performed as distinct services. (The core compliance focus remains documentation and policy alignment, rather than “modifier tactics.”)
If ultrasound guidance is used to perform a peripheral nerve block, reporting of ultrasound guidance (e.g., CPT 76942) may be appropriate when performed and documented according to payer requirements. ACEP reimbursement guidance discusses this billing concept for nerve blocks and highlights that bundling rules still apply when the block is part of another procedure.
The NCCI Policy Manual describes general correct coding principles and the concept of the medical/surgical package, including services that are considered integral to other procedures. In this framework, local/regional anesthesia and services performed as part of surgical anesthesia are typically not separately reportable. This is a central risk area for 64450 because peripheral nerve blocks are frequently performed to facilitate another procedure (e.g., laceration repair, incision and drainage, minor orthopedic procedures). When the block is merely the anesthesia component of the primary procedure, reporting 64450 is commonly non-compliant and will be denied or recouped.
Compliance principle (NCCI): Use 64450 as a separately reported service only when it is a distinct diagnostic/therapeutic nerve block service—not when it represents anesthesia inherent to another billed procedure.
NCCI policy regarding E/M services explains that for minor procedures, the typical pre-service evaluation and decision-making related to performing the procedure is generally included. A separate E/M on the same date must be supported as a significant, separately identifiable service beyond the usual work associated with the procedure. This is why routine “block-only” visits are often not defensible as separate E/M billing unless a distinct evaluation/management service is documented.
Medicare LCD guidance for peripheral nerve blocks includes specific utilization controls designed to prevent repetitive injections without durable benefit. Key policy concepts include:
Operationally, practices should track injection history by specific nerve/branch and date to avoid inadvertent frequency violations, and they should document response trajectories (progressively sustained relief) when repeating blocks. The LCD explicitly advises exploring alternative therapeutic options if the patient does not achieve progressively sustained relief after two to three repeat injections on the same site.
| Code | Core Service | Best Use Case | High-Risk Misuse Pattern | Key Policy Anchor |
|---|---|---|---|---|
| 64450 | Injection, anesthetic agent and/or steroid; other peripheral nerve or branch | Named peripheral nerve/branch block when no more specific nerve-block CPT applies | Used as a generic “pain injection” or used for anesthesia integral to another procedure | NCCI surgical package bundling; Medicare policy against non-nerve injections billed as 64450 |
| 76942 | Ultrasound guidance for needle placement (when separately reportable) | Reported when ultrasound guidance is used and documented per payer requirements | Billed without documentation or when guidance is bundled/included by payer rule | ACEP guidance discusses ultrasound billing with nerve blocks |
| 64455 (contextual comparator) | Plantar common digital nerve block / Morton’s neuroma-related coding pathway | Use the specific code when the service matches Morton’s neuroma injection/nerve block context | Billing 64450 for Morton’s neuroma-related injections when Medicare expects the specific code pathway | Medicare billing/coding guidance on injections including Morton’s neuroma |
| Soft-tissue injection families (contextual comparator) | Tendon/ligament and related injection coding pathways | Use when documentation supports tendon/ligament/tunnel syndrome injection services rather than nerve blockade | Calling a tendon/ligament injection a “nerve block” to bill 64450 | Medicare billing/coding guidance distinguishes injection categories |
Setting: Emergency Department
Service: Peripheral nerve block performed to provide focused analgesia for a focal injury, documented with named nerve target and laterality; ultrasound guidance used and documented.
Coding logic: 64450 may be appropriate if the block is a distinct therapeutic service and not merely anesthesia integral to another billable procedure. If ultrasound guidance is separately reportable and documented, guidance reporting may be considered subject to payer rules.
Documentation tip: Clearly document the nerve target, technique, medication and dose, patient response, and whether the block was performed as a separate therapeutic intervention versus anesthesia for a procedure.
Setting: Outpatient clinic
Service: Diagnostic peripheral nerve block of a named nerve/branch to confirm pain generator prior to longer-term management.
Coding logic: Align documentation to Medicare policy expectations: anatomically specific nerve target, plausible diagnosis and symptom pattern, and an appropriate treatment plan if relief is transient or absent.
Documentation tip: Record baseline symptoms, distribution, exam findings, and post-block response to support medical necessity and clinical reasoning.
Setting: Outpatient pain management
Service: A patient receives repeated blocks of the same nerve/branch within a short timeframe with diminishing benefit.
Coding risk: Medicare LCD language states that more than three injections per anatomic site in a six-month period will be denied, and it expects progressively sustained relief after repeat injections; otherwise alternative options should be explored.
Defensive documentation: Track prior dates/response and document why any additional injection is clinically justified; if policy thresholds are exceeded, anticipate denial and consider ABN/coverage pathways as appropriate under Medicare rules.
Setting: Podiatry/orthopedics clinic
Service: Injection performed for a foot pain condition that resembles a nerve block in lay terminology, but documentation indicates a different injection category or a more specific code pathway.
Coding logic: Medicare billing/coding guidance for injection services (including Morton’s neuroma-related contexts) is commonly used to enforce correct code selection and prevent miscoding as 64450 when the service matches another code pathway.
Documentation tip: Ensure the note states whether this is a true nerve block (named nerve target) versus soft-tissue injection; code accordingly.
© Copyright 2026 American Medical Association. All rights reserved.
An injection of an anesthetic agent and/or steroid into a peripheral nerve or branch is a medical procedure commonly referred to as a peripheral nerve block. This procedure is specifically indicated for peripheral nerves or branches that are not covered by other specific CPT® codes. The primary goal of this intervention is to provide localized pain relief by blocking sensation from the targeted nerve. Typically, this procedure is performed on nerves located in the arms or legs, where the specific nerve or branch requiring treatment is carefully identified prior to the injection. The process begins with the disinfection of the skin over the planned puncture site to minimize the risk of infection. Following this, a needle is inserted into the skin, and aspiration is performed to confirm that the needle is not positioned within a blood vessel. Once confirmed, the anesthetic agent and/or steroid is injected, effectively blocking the nerve's ability to transmit pain signals, thereby alleviating discomfort in the affected area.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.